Source: Annual Congress 2004 - The fourth ERS - free paper symposium on interdisciplinary basic and clinical surfactant research
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
K. Raymondos, U. Molitoris, J. Ahrens, B. Hillmer, A. D. Postle, W. Bernhard, J. Braun, H. C. Pape, S. Piepenbrock (Hannover, Heidelberg, Luebeck, Germany; Southampton, United Kingdom). Surfactant and inflammation in patients predisposed for ARDS after multiple trauma. Eur Respir J 2004; 24: Suppl. 48, 1308

Member's Comments

No comment yet.

Related content which might interest you: ARDS and sepsis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=253 Year: 2005 Exogenous surfactant administration in patients at high risk to develop ARDS after multiple trauma Source: Eur Respir J 2001; 18: Suppl. 33, 7s Year: 2001 Principles of surfactant-therapy ARDS in patients with severe inhalation trauma Source: Annual Congress 2008 - Acute lung injury and weaning Year: 2008 Surfactant treatment leads to a sustained improvement of oxygenation only in severe pediatric ARDS without pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 318s Year: 2001 Surfactant therapy for acute lung injury and other lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 210s Year: 2003 Role of heat shock proteins in the lungs of acute lung injury Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management Year: 2006 Exogenous pulmonary surfactant combined with recruitment maneuver in prevention of alveolar derecruitment in rabbits with acute respiratory distress syndrome Source: Annual Congress 2007 - Lung recruitment Year: 2007 The impact of two partial ventilatory support modalities on lung histology and inflammatory mediators in a model of acute respiratory distress syndrome Source: Annual Congress 2007 - Acute lung injury and inflammation Year: 2007 The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 347s Year: 2006 Ventilator-induced lung injury Source: Eur Respir J 2003; 22: 2S-9S Year: 2003 Surfactant therapy for persistent atelectasis developed in the children with acute bronchopneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 629s Year: 2005 Mechanisms of acute lung injury Source: Annual Congress 2005 - In vivo - approaches to lung injury Year: 2005 Surfactant therapy in acute lung injury/acute respiratory distress syndrome Source: Eur Respir Mon 2012; 55: 54-64 Year: 2012 Exogenous pulmonary surfactant administration for acute respiratory distress syndrome in post-operative patients Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 ARDS and ventilator induced lung injury Source: Annual Congress 2013 –ERS/NEJM joint session: “Novel Strategies for Ventilating Patients with ARDS" Year: 2013 Difference of immune response in patients with severe acute pneumonia and lung abscesses Source: Eur Respir J 2004; 24: Suppl. 48, 189s Year: 2004 Proteinomics and ARDS Source: Annual Congress 2007 - Acute respiratory distress syndrome: from basic science to bedside Year: 2007 Delayed neutrophil apoptosis may predispose to lung injury in chronic lung disease of prematurity Source: Eur Respir J 2007; 30: Suppl. 51, 393s Year: 2007